MedChemExpress Revenue and Competitors

Monmouth Junction, NJ

Location

N/A

Total Funding

Chemicals

Industry

Estimated Revenue & Valuation

  • MedChemExpress's estimated annual revenue is currently $75M per year.(i)
  • MedChemExpress's estimated revenue per employee is $862,069

Employee Data

  • MedChemExpress has 87 Employees.(i)
  • MedChemExpress grew their employee count by 53% last year.

MedChemExpress's People

NameTitleEmail/Phone
1
VP Technology, Operation and SupportReveal Email/Phone
2
Regional Sales Director New EnglandReveal Email/Phone
3
Sales ManagerReveal Email/Phone
4
PresidentReveal Email/Phone
5
Technical Sales Specialist (AU & NZ)Reveal Email/Phone
6
Product and Service SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M21-38%N/AN/A
#2
$35M1793%N/AN/A
#3
N/A48590%N/AN/A
#4
$35M300N/AN/AN/A
#5
$750M14388%N/AN/A
#6
$35M3583%N/AN/A
#7
$300M232-4%N/AN/A
#8
$7.5M716%N/AN/A
#9
$75M9918%N/AN/A
#10
N/A814%N/AN/A
Add Company

What Is MedChemExpress?

MedChemExpress has an experienced team of synthesis chemists. Led by excellent scientists, our chemical synthesis team is capable of supporting all kinds of chemistry projects, even multiple step synthesis of complex molecules, such as metabolites and steroids. MedChemExpress has always been committed to develop the most optimized synthetic route and high-quality products that exceed international standards. With rich experiences in preparing a large number of different bioactive molecules, we can provide your customized compounds more rapidly than other companies. Our company is dedicated to providing customers with all kinds of high quality bioactive small molecules, including inhibitors, antagonists, agonists and modulators. We own a comprehensive product line and offer professional after-sale services to achieve customer satisfaction. Our products have been widely used in various fields of biopharmaceutical research and development, especially in the research focus areas such as cancer, infection, autoimmune diseases, diabetes, cardiovascular diseases and neurodegenerative diseases. Our tech-support team classifies products into Apoptosis, Epigenetics, Wnt/Hedgehog/Notch, PI3K/Akt/mTOR, etc., according to the basic biological theory of signaling pathways which cover all aspects of the pathogenesis of diseases.

keywords:N/A

N/A

Total Funding

87

Number of Employees

$75M

Revenue (est)

53%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M900%N/A
#2
$35M1318%N/A
#3
$19.7M136-1%N/A
#4
$46.9M1740%N/A
#5
$53.2M1821%$22.6M